FDA targets early September for approving Pfizer's Covid-19 vaccine

.cms-textAlign-left{text-align:left;}.cms-textAlign-center{text-align:center;}.cms-textAlign-right{text-align:right;}.cms-magazineStyles-smallCaps{font-variant:small-caps;}

The Food and Drug Administration is expected to approve Pfizer’s coronavirus vaccine in a matter of weeks by early September, amid a resurgence of cases that has heightened pressure on the administration to get more Americans vaccinated.

While the agency had long eyed the fall for granting full licensure, officials have recently accelerated their work, and now hope to finalize approval in a matter of weeks, according to three people familiar with the matter.

→ Continue reading at Politico

[ufc-fb-comments url="http://www.newyorkmetropolitan.com/news/fda-targets-early-september-for-approving-pfizers-covid-19-vaccine"]

Latest Articles

Related Articles